<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03106116</url>
  </required_header>
  <id_info>
    <org_study_id>EECP-3</org_study_id>
    <nct_id>NCT03106116</nct_id>
  </id_info>
  <brief_title>Efficacy of Enhanced External Counterpulsation on Ventricular Function</brief_title>
  <acronym>EECPVF</acronym>
  <official_title>A Prospective, Randomized Study of Enhanced External Counterpulsation Therapy on Ventricular Function in Patients With Coronary Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the efficacy of Enhanced External
      Counterpulsation (EECP) therapy on ventricular function in patients with coronary heart
      disease
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with coronary heart disease will be randomized into two groups:

      standard medical treatment and standard medical treatment plus EECP intervention. Ventricular
      structure and function will be measured and compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2017</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in heart function</measure>
    <time_frame>7 weeks</time_frame>
    <description>Change from baseline in heart function assessed by trans- thoracic echocardiography at 7 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac chamber diameter</measure>
    <time_frame>7 weeks</time_frame>
    <description>Change from baseline in cardiac chamber diameterat 7 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ventricular wall thickness</measure>
    <time_frame>7 weeks</time_frame>
    <description>Change from baseline in ventricular wall thickness</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Enhanced External Counterpulsation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental: Enhanced External Counterpulsation (EECP) intervention on top of guideline- driven standard medical therapy for coronary heart disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Guideline- driven standard medical therapy for 7 weeks without Enhanced External Counterpulsation intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Experimental: Enhanced External Counterpulsation</intervention_name>
    <description>Enhanced External Counterpulsation (EECP) is a technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure externally by applying a negative pressure to the lower extremities during cardiac systole. EECP therapy has been approved by the United States Food and Drug Administration (FDA) for the treatment of refractory angina and heart failure. Administration of 35-36 hours EECP therapy over a 7 week period, one hour session every working day.</description>
    <arm_group_label>Enhanced External Counterpulsation</arm_group_label>
    <other_name>EECP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard medical therapy</intervention_name>
    <description>Guideline- driven standard medical treatment for 7 weeks</description>
    <arm_group_label>Enhanced External Counterpulsation</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>Guideline- driven standard medical therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  More than 50% stenosis of left main trunk and 3 epicardial coronary arteries and their
             large branches showed by coronary angiography

          -  Or history of myocardial infarction

          -  Or history of prior revascularization

          -  Signed informed consent to participate in the study

        Exclusion Criteria:

          -  Clinically significant valvular heart disease

          -  Aortic aneurysm

          -  Congenital heart disease

          -  Acute myocarditis

          -  Arrhythmias significantly interfere with the triggering of the EECP device

          -  History of cerebral hemorrhage

          -  Hemorrhagic disease

          -  Lower limb infection, phlebitis

          -  Deep venous thrombosis

          -  Malignant disease

          -  International normalized ratio (INR) &gt; 2.5

          -  Uncontrolled hypertension, defined as systolic blood pressure &gt; 180mmHg or diastolic
             blood pressure &gt; 110mmHg

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Zhang, M. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhensheng Zheng, M. D.</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan Zhang, M. D.</last_name>
    <phone>8620-87755766</phone>
    <phone_ext>8161</phone_ext>
    <email>zhyan3@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qiang Xie, M. D.</last_name>
    <phone>8620-87755766</phone>
    <phone_ext>8161</phone_ext>
    <email>qiangxie@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital, Sun Yat- sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weiwei Zhang, PhD</last_name>
      <phone>020-87334871</phone>
      <email>zhweiw2@mail.sysu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xiaoxu Zhou, PhD</last_name>
      <phone>020-87780263</phone>
      <email>xiaoxuzou_sysu@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>April 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2017</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Yan Zhang</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Coronary Heart Disease</keyword>
  <keyword>Ventricular Function</keyword>
  <keyword>Vascular Endothelium</keyword>
  <keyword>Counterpulsation, External</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

